These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 3100576)
61. ZFN-Mediated In Vivo Genome Editing Corrects Murine Hurler Syndrome. Ou L; DeKelver RC; Rohde M; Tom S; Radeke R; St Martin SJ; Santiago Y; Sproul S; Przybilla MJ; Koniar BL; Podetz-Pedersen KM; Laoharawee K; Cooksley RD; Meyer KE; Holmes MC; McIvor RS; Wechsler T; Whitley CB Mol Ther; 2019 Jan; 27(1):178-187. PubMed ID: 30528089 [TBL] [Abstract][Full Text] [Related]
62. Overexpression of the human lysosomal enzyme alpha-L-iduronidase in Chinese hamster ovary cells. Kakkis ED; Matynia A; Jonas AJ; Neufeld EF Protein Expr Purif; 1994 Jun; 5(3):225-32. PubMed ID: 7950365 [TBL] [Abstract][Full Text] [Related]
63. Ocular lesions in canine mucopolysaccharidosis I and response to enzyme replacement therapy. Newkirk KM; Atkins RM; Dickson PI; Rohrbach BW; McEntee MF Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5130-5. PubMed ID: 21436264 [TBL] [Abstract][Full Text] [Related]
65. Hematopoietic stem cell transplantation effects on spinal cord compression in Hurler. Ferrara G; Maximova N; Zennaro F; Gregori M; Tamaro P Pediatr Transplant; 2014 May; 18(3):E96-9. PubMed ID: 24483599 [TBL] [Abstract][Full Text] [Related]
66. Improvements in mucopolysaccharidosis I mice after adult retroviral vector-mediated gene therapy with immunomodulation. Ma X; Liu Y; Tittiger M; Hennig A; Kovacs A; Popelka S; Wang B; Herati R; Bigg M; Ponder KP Mol Ther; 2007 May; 15(5):889-902. PubMed ID: 17311010 [TBL] [Abstract][Full Text] [Related]
67. Enzyme-replacement therapy in mucopolysaccharidosis I. Kakkis ED; Muenzer J; Tiller GE; Waber L; Belmont J; Passage M; Izykowski B; Phillips J; Doroshow R; Walot I; Hoft R; Neufeld EF N Engl J Med; 2001 Jan; 344(3):182-8. PubMed ID: 11172140 [TBL] [Abstract][Full Text] [Related]
68. Gene therapy of the brain in the dog model of Hurler's syndrome. Ciron C; Desmaris N; Colle MA; Raoul S; Joussemet B; Vérot L; Ausseil J; Froissart R; Roux F; Chérel Y; Ferry N; Lajat Y; Schwartz B; Vanier MT; Maire I; Tardieu M; Moullier P; Heard JM Ann Neurol; 2006 Aug; 60(2):204-13. PubMed ID: 16718701 [TBL] [Abstract][Full Text] [Related]
69. Bone marrow transplant in a case of mucopolysaccharidosis I Scheie phenotype: skin ultrastructure before and after transplantation. Navarro C; Dominguez C; Costa M; Ortega JJ Acta Neuropathol; 1991; 82(1):33-8. PubMed ID: 1950476 [TBL] [Abstract][Full Text] [Related]
70. Clinical ultrastructural and tissue culture studies in a possible compound Hurler-Scheie case. Tondeur M; Vamos-Hurwitz E; Cantz M; Cremer N; Libert J; Pardou A Acta Paediatr Belg; 1976; 29(2):109-15. PubMed ID: 826105 [No Abstract] [Full Text] [Related]
72. Shotgun proteomics reveals possible mechanisms for cognitive impairment in Mucopolysaccharidosis I mice. Baldo G; Lorenzini DM; Santos DS; Mayer FQ; Vitry S; Bigou S; Heard JM; Matte U; Giugliani R Mol Genet Metab; 2015 Feb; 114(2):138-45. PubMed ID: 25541102 [TBL] [Abstract][Full Text] [Related]
73. Mucopolysaccharidosis type I. Wraith JE; Jones S Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091 [TBL] [Abstract][Full Text] [Related]
74. Retrovirus-mediated transfer of the human alpha-L-iduronidase cDNA into human hematopoietic progenitor cells leads to correction in trans of Hurler fibroblasts. Huang MM; Wong A; Yu X; Kakkis E; Kohn DB Gene Ther; 1997 Nov; 4(11):1150-9. PubMed ID: 9425437 [TBL] [Abstract][Full Text] [Related]
75. Reversal of lysosomal storage in brain of adult MPS-I mice with intravenous Trojan horse-iduronidase fusion protein. Boado RJ; Hui EK; Lu JZ; Zhou QH; Pardridge WM Mol Pharm; 2011 Aug; 8(4):1342-50. PubMed ID: 21667973 [TBL] [Abstract][Full Text] [Related]
76. Prenatal diagnosis of Hurler's syndrome--biochemical studies on the affected fetus. Ikeno T; Minami R; Wagatsuma K; Fujibayashi S; Nakao T; Abo K; Tsugawa S; Taniguchi S; Takasago Y Hum Genet; 1981; 59(4):353-9. PubMed ID: 6800929 [TBL] [Abstract][Full Text] [Related]
77. Fluorometric assay of alpha-L-iduronidase in serum for detection of affected and carrier animals in a canine model of mucopolysaccharidosis I. Shull RM; Hastings NE Clin Chem; 1985 Jun; 31(6):826-7. PubMed ID: 3922649 [TBL] [Abstract][Full Text] [Related]
78. Evaluation of non-reducing end pathologic glycosaminoglycan detection method for monitoring therapeutic response to enzyme replacement therapy in human mucopolysaccharidosis I. Vera MU; Le SQ; Victoroff A; Passage MB; Brown JR; Crawford BE; Polgreen LE; Chen AH; Dickson PI Mol Genet Metab; 2020 Feb; 129(2):91-97. PubMed ID: 31630958 [TBL] [Abstract][Full Text] [Related]
79. Radiographic findings in a canine model of mucopolysaccharidosis I. Changes associated with bone marrow transplantation. Shull RM; Walker MA Invest Radiol; 1988 Feb; 23(2):124-30. PubMed ID: 3125125 [TBL] [Abstract][Full Text] [Related]
80. Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrow. Fairbairn LJ; Lashford LS; Spooncer E; McDermott RH; Lebens G; Arrand JE; Arrand JR; Bellantuono I; Holt R; Hatton CE; Cooper A; Besley GT; Wraith JE; Anson DS; Hopwood JJ; Dexter TM Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2025-30. PubMed ID: 8700879 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]